Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Medtronic, Inc.    MDT   US5850551061

MEDTRONIC, INC. (MDT)

51
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/16/2014 04/17/2014 04/21/2014 04/22/2014 04/23/2014 Date
58.49(c) 58.55(c) 58.94(c) 58.3(c) 58.355 Last
5 001 101 6 055 995 3 851 560 4 167 337 2 343 797 Volume
+0.76% +0.10% +0.67% -1.09% +0.09% Change
More quotes
Company
Medtronic, Inc. is a medical technology company, which provides innovative products and therapies for use by medical professionals to meet the health care needs of their patients. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal... 
Surperformance© rating of Medtronic, Inc.
Trading Rating : Investor Rating :
More about the company
Chart MEDTRONIC, INC.
Duration : Period :
Medtronic, Inc. Technical Analysis Chart | MDT | US5850551061 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 17 006 M
EBIT 2014 5 404 M
Net income 2014 3 634 M
Debt 2014 5 921 M
Yield 2014 1,88%
Sales 2015 17 641 M
EBIT 2015 5 633 M
Net income 2015 4 025 M
Debt 2015 7 787 M
Yield 2015 2,00%
PER 2014 16,09
PER 2015 14,44
EV / Sales 2014 3,78x
EV / Sales 2015 3,75x
Capitalization 58 348 M
More Financials
Latest news on MEDTRONIC, INC.
2h ago ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Tr..
3h ago MEDTRONIC : Update on CoreValve Federal District Court Ruling
3h ago MEDTRONIC : Federal Appeals Court Agrees to Medtronic Request to Postpone Injunc..
5h ago MEDTRONIC : Stock Price Movements, Collaborations, Earnings Releases, Upcoming E..
1d ago MEDTRONIC : Business Roundtable Releases 2014 Sustainability Report
1d ago Denervation fails to lower blood pressure
1d ago INTRICON : Reports 2014 First-Quarter Results
1d ago MEDTRONIC : MILITARY Integrity Stents Sought by U.S. Navy
1d ago MEDTRONIC : MILITARY Pulsar Generators Sought by U.S. Navy
1d ago MEDTRONIC : Endurant AAA Stent Graft from Medtronic Continues Exceptional Long-T..
1d ago Arca Biopharma Screens First Patient in Phase 2B/3 Clinical Trial Evaluating ..
2d ago MEDTRONIC : says CoreValve injunction is postponed
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
Medtronic, Inc. : Income Statement Evolution
More Financials
EPS Revisions
Medtronic, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF